May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Insulin Can Stimulate Vascular Cell Growth in the Eye of Transgenic Mice
Author Affiliations & Notes
  • B. Cho
    Ophthalmology, University of Missouri, Columbia, MO
  • D.P. Hainsworth
    Ophthalmology, University of Missouri, Columbia, MO
  • L. Reneker
    Ophthalmology, University of Missouri, Columbia, MO
  • Footnotes
    Commercial Relationships  B. Cho, None; D.P. Hainsworth, None; L. Reneker, None.
  • Footnotes
    Support  NIH Grant EY13146
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3898. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Cho, D.P. Hainsworth, L. Reneker; Insulin Can Stimulate Vascular Cell Growth in the Eye of Transgenic Mice . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3898.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Diabetic retinopathy (DR), a blinding complication of diabetes, is thought to be caused by changes in the retinal vasculature. Insulin–like growth factor (IGF) has been implicated in the development of DR. IGF–1 over–expression in the eyes of transgenic mice causes changes characteristic of DR including expression of vascular endothelial growth factor (VEGF). Insulin, the mainstay of glucose control in diabetics, has similar biological functions as IGF–1. Our purpose was to examine the effects of insulin on ocular vasculature system development in transgenic mice. Methods: Transgenic mice that over–express insulin in the lens were examined by histology, scanning electron microscopy (SEM), and immunohistochemical staining. The levels of VEGF and hypoxia inducible factor (HIF)–1α mRNA were measured by semi–quantitative reverse transcriptase (RT)–PCR. Results: Six transgenic lines expressing variable levels of insulin were examined. Transgenic mice displayed abnormalities in the tunica vasculosa lentis (TVL) surrounding the lens. In contrast to wild–type, transgenic mice demonstrated increased and persistent development of the TVL. SEM demonstrated increased vessel density, branching, and pericytes in the TVL of the transgenic mice. Additionally, it was found that elevated levels of insulin led to increased expression of VEGF. Conclusions: Insulin, like IGF–1, can stimulate vascular growth in the eye. Interestingly, our findings suggest a mechanism for the transient worsening of DR that occurs with intensive insulin treatment as observed in the Diabetes Control and Complications Trial (DCCT). We propose that insulin, like IGF–1, may play a role in the development of DR.

Keywords: diabetes • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×